Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings

Treloar, Carla; Holt, Martin

doi:10.1071/ah080570

Cited by 34 publications

(34 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A review of the literature highlights ‘readiness’ as an important construct in an individual's decision-making to undergo treatment but there is little consensus on its definition [19]–[21]. In one study, people with addictive behaviours were found to move through the following stages of readiness and change: from pre-contemplation (no intention to change) → contemplation (thinking of change) → preparation for action (behaviour, experiences or environment) → maintenance (prevent relapse and consolidate gains) [22].…”

Section: Introductionmentioning

confidence: 99%

A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners

Yap

Carruthers

Thompson³

et al. 2014

PLoS ONE

View full text Add to dashboard Cite

BackgroundHepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations.Method and FindingsWe undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners.ConclusionThis study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.

show abstract

Section: Introductionmentioning

confidence: 99%

A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners

Yap

Carruthers

Thompson³

et al. 2014

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…In previous research, reasons for patients in OMT not wanting HCV treatment are mainly having heard stories about side effects; absence of symptoms; and lack of information about treatment options [18,22]. These reasons might be applicable to our results: The number of patients reporting knowing something about HCV treatment increased significantly from baseline to follow-up six months later.…”

Section: Discussionmentioning

confidence: 44%

“…The purpose of OMT service is not only to treat drug dependence, but also to notify problems concerning the patients' somatic health. This could be further stressed by encouraging the individual with more information, motivational interviewing etcetera, as supported by previous research [21,22]. It is also important to create structures in the health care system which facilitates quick and easy referral from OMT to HCV treatment.…”

Section: Discussionmentioning

confidence: 99%

“…A qualitative, Australian study on 77 drug users currently or recently in drug treatment (mostly OMT) identified some barriers to HCV treatment; lacking knowledge and awareness of HCV and treatment options; having heard stories about treatment side effects; and low interest in HCV treatment in those not bothered from HCV-related symptoms [22].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Attitudes towards Hepatitis C and Treatment Willingness in Injection Drug Users: A Follow-up Interview Study

Fornvik¹

2015

J Alcohol Drug Depend

View full text Add to dashboard Cite

Many injection drug users are infected with hepatitis C virus (HCV), yet few are treated. With opiate maintenance treatment, expected life length increases, and the incitement increases to treat HCV in order to avoid long term complications. The aim of the present study was to investigate attitudes towards HCV and HCV treatment willingness among opiate-dependent injection drug users at Malmö needle exchange program, through interviews just before entering opiate maintenance treatment and after 6 months in opiate maintenance treatment. Heroin-dependent injection drug users were recruited from Malmö needle exchange program October 2011 -April 2013. They had a structured baseline interview (N=83), led by social workers. After 6 months, all patients who successfully entered opiate maintenance treatment and were still enrolled (N=56) had a follow-up interview. Correlations with treatment willingness were calculated using Pearson's Chi-Square test. Change over time was determined by McNemar Test. A majority at both baseline and follow-up wanted more information about HCV, but HCV-positive subjects did not feel affected by their HCV status. No significant change in treatment willingness was found after 6 month in opiate maintenance treatment, neither were any factors significantly associated with treatment willingness found. We conclude that there is need for inclusion of more information about and easy referral to HCV therapy as part of opiate maintenance treatment.

show abstract

“…Despite the international awareness about the long-term consequences of HCV and recent shifts in guidelines related to antiviral therapy for patient in OAT recipients, only a minority are enrolled in antiviral therapy (McCormick et al, 2008;Treloar and Holt, 2008). In our study, less than a quarter of a preselected sample eventually initiated treatment.…”

Section: Discussionmentioning

confidence: 72%

Perceived Barriers to Hepatitis C Therapy for Patients Receiving Opioid Agonist Treatment

Zickmund

Campbell

Tirado

et al. 2012

Journal of Addiction Medicine

View full text Add to dashboard Cite

show abstract

Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings

Cited by 34 publications

References 32 publications

A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners

A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners

Attitudes towards Hepatitis C and Treatment Willingness in Injection Drug Users: A Follow-up Interview Study

Perceived Barriers to Hepatitis C Therapy for Patients Receiving Opioid Agonist Treatment

Contact Info

Product

Resources

About